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Abstract.  The role of acetylcholine receptors in the 
control of chick myoblast fusion in culture has been 
explored.  Spontaneous fusion of myoblasts was in- 
hibited by the nicotinic acetylcholine receptor antago- 
nists ct-bungarotoxin,  Naja naja toxin and monoclonal 
antibody mcAb 5.5.  The muscarinic antagonists QNB 
and n-methyl scopolamine were without effect. Atro- 
pine had no effect below 1 p.M, where it blocks mus- 
carinic  receptors; at higher concentrations,  when it 
blocks nicotinic receptors also, atropine inhibited myo- 
blast fusion.  The inhibitions  imposed by acetylcholine 
receptor antagonists  lasted for ~12 h;  fusion stimu- 
lated by other endogenous substances then took over. 
The inhibition was limited to myoblast fusion. The 
increases in cell number,  DNA content,  the level of 
creatine phosphokinase activity (both total and muscle- 
specific isozyme) and the appearance of heavy chain 
myosin, which accompany muscle differentiation,  fol- 
lowed a normal time course. Pre-fusion myoblasts, 
fusing myoblasts, and young myotubes specifically 
bound labeled ¢t-bungarotoxin,  indicating  the presence 
of acetylcholine receptors.  The nicotinic acetylcholine 
receptor agonist,  carbachol,  induced uptake of 
[14C]Guanidinium  through the acetylcholine receptor. 
Myoblasts, aligned myoblasts and young myotubes ex- 
pressed the synthetic enzyme Choline acetyltransferase 
and stained positively with antibodies against acetyl- 
choline.  The appearance of ChAT activity in myogenic 
cultures was prevented by treatment with BUDR; non- 
myogenic cells in the cultures expressed ChAT at a 
level which was too low to account for the activity in 
myogenic cultures.  We conclude that activation of the 
nicotinic acetylcholine receptor is part of the mecha- 
nism controlling spontaneous myoblast fusion and that 
myoblasts synthesize an endogenous,  fusion-inducing 
agent that activates the nicotinic ACh receptor. 
I 
N the previous paper we reported that agents that prob- 
ably bring  about depolarization  of fusion competent 
myoblasts can initiate myoblast fusion (Entwistle  et al., 
1988). In all cases, these agents were only effective when cal- 
cium ions were able to cross the membrane, suggesting that 
depolarization  may open  voltage-gated  calcium  channels. 
The resultant entry of calcium ions triggers myoblast fusion. 
There is already evidence for prostanoids  as an important 
endogenous stimulus  for myoblast fusion (Entwistle  et al., 
1986), possibly generating  depolarization  by increasing  the 
permeability to chloride ions (Entwistle et al., 1988). In the 
course of these experiments  we showed  that an agonist  at 
the acetylcholine receptor,  carbachol, also was able to initi- 
ate myoblast fusion,  through  a separate pathway from that 
triggered  by prostanoids.  Acetylcholine receptors appear at 
high density in the myoblast membrane after myotube forma- 
tion  (see Fambrough,  1979 for review)  but are present on 
chick myoblasts  at low density and can be detected either 
electrophysiologically  or by the binding  of [12~I]ct-bungaro- 
toxin  (Smilowitz  and  Fischbach,  1978). In this  paper  we 
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show that nicotinic acetylcholine receptors play a role in the 
process of myogenesis  in vitro and that myoblasts express 
choline acetyltransferase  and specifically bind antibodies to 
acetylcholine.  A brief report of some of these results has al- 
ready appeared (Bevan et al.,  1985). 
Materials and Methods 
Myoblast Cultures 
Culture preparation and the schedule for the addition of prostanoid synthesis 
inhibitors were as described in the previous paper (Entwistle et al.,  1987). 
The schedule for other manipulations of fusion are given in the legends to 
the appropriate  figures. Except where indicated,  all reagents came from 
Sigma Chemical Co.  (London, U.K.). 
Autoradiography 
Autoradiogmphs of cultures labeled with ~2SI-labeled a-bungarotoxin were 
made and processed as described elsewhere (Bevan and Steinhach, 1977; 
Adams and  Bevan,  1985).  In brief,  ~-bungarotoxin was iodinated  (125I, 
Amersham, U.K.) by the chloramine T method and fractionated on a Sepha- 
dex G-25 column. The resultant [~2~I]ct-bungarotoxin had an initial specific 
activity of 170-230 Ci/mmol  -j.  Cultures were incubated with  10  -a M  la- 
beled ¢t-bungarotoxin for 60 min at room temperature, followed by extensive 
washing for 30 rain to remove unbound radioligand. In some cases 10  -4 M 
carbachol or D-tubocurare was added before and during exposure to labeled 
tt-bungarotoxin to inhibit toxin binding to the acetylcholine receptor.  La- 
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temperature  for  1 h,  washed,  dehydrated through a  graduated  series of 
methanols, and then air dried.  The cultures were coated with a thin film 
of nuclear gel emulsion (Ilford K2, diluted 1:1 with water at 40°C) and ex- 
posed at 4°C for 4-28 d  before development. 
Assay of Choline Acetyl Transferase  Activity 
Choline acetyl transferase activity was determined using the method of Fon- 
num (1975), modified to take account of the low levels of activity pertaining 
in cultured myoblasts. The dishes were rapidly rinsed twice with ice cold, 
50 mM phosphate buffer containing 10 mM EDTA, made up to isotonicity 
with sodium chloride, at pH 7.4, followed by a rinse in the same solution, 
but lacking EDTA. Cells were gently scraped from the bottom of the dish 
with a silicone rubber stopper and harvested in 250 I.tl of EDTA-free buffer 
in an Eppendorf tube. The tubes were spun for 4  min at 500 g  and most 
of the supernatant removed, leaving a total volume of ~27 ~1.1 p.l of EDTA- 
free buffer containing either 5  U of acetylcholine esterase or  1 mM phys- 
ostigmine was then added to each tube. Total protein was assayed in parallel 
by the micro-assay of Bradford (1976) to assess cell loss during these proce- 
dures. 
The reaction was started by adding 0.09  ~tCi [~4C]acetyl  CoA (Amer- 
sham) in 2  I.tl of EDTA-free buffer containing 1 mM acetyl CoA (Sigma 
Chemical Co.), 40 mM choline chloride and 2.5% Triton X-100 (vol/vol) 
which gives a final concentration of choline of 2.7 mM. The Triton ensured 
efficient cell lysis. The mixture was incubated for  15 min at 37°C and the 
reaction stopped with 2.5 ml of ice cold EDTA containing buffer at pH 7.0. 
A  100-pl aliquot of the suspension was taken for protein assay. The re- 
mainder  received  1  ml  of  1%  (wt/vol)  tetraphenylboron  in  acetonitryl 
(BDH) followed by 4 ml of scintiUation fluid (Ready-solv, Beckman). It was 
then vortex-mixed, spun at 3,500 g  for 113 min, and the aqueous phase re- 
moved with a silanized Pasteur pipette. The organic phase was counted in 
a Beckman Model LS 7500 or LS 1801 liquid scintillation counter. A blank 
set of dishes was carried through the same procedures to assess the amount 
of Acetyl CoA partitioned into the organic phase. ChAT activity was calcu- 
lated from the difference in radioactivity between dishes treated with phy- 
sostigmine and those treated with acetylcholine esterase. The results are ex- 
pressed as pmol/min per mgm protein on the basis of the protein content 
determined in the aliquots taken before counting. 
To determine carnitine acetyltransferase activity, 10 mM carnitine (final 
concentration) was substituted for choline in the assay described above and 
the reaction stopped with ice-cold EDTA in buffer at pH 3.0 to enhance the 
entry of acetylcarnitine into the organic phase. The activity in myoblasts was 
calculated by comparison with a standard curve constructed using pigeon 
breast carnitine acetyltransferase (Sigma Chemical Co.). If the reaction was 
stopped with EDTA buffered at pH 7.0, as for choline, the level of activity 
in the organic phase fell to background levels, confirming that the extraction 
method normally excludes acetylcarnitine  (Fonnum,  1975; Tucek et al., 
1978). By contrast, in controls using labeled acetylcholine more than 80% 
of the initial radioactivity was partitioned into the organic phase; this was 
abolished by the inclusion of AChE in the incubation medium. 
lmmunocytochemistry 
The appearance of the muscle-specific form of Creatine phosphokinase and 
of the myosin-heavy  chain was detected with antibodies using a double stain- 
ing technique. A rabbit polyclonal antibody to the muscle specific CPK iso- 
zyme was kindly donated by J. C. Perriard (University of Zurich, Zurich, 
Switzerland); a mouse monoclonal myosin antibody came from G. Dhoot 
(University of Birmingham, Birmingham, U.K.). The cultures were fixed 
in 1:1 acetone/methanol at -20°C for 1.5 min, air dried, and stored at 4°C. 
For assay each dish was preincubated at 37°C with 1 ml PBS, pH 7.4, con- 
taining 10% horse serum, rinsed thoroughly with PBS and then incubated 
for  1 h at 37°C in a  high humidity atmosphere with  1:100 dilution of the 
anti-muscle specific CPK antibody. They were then rinsed thoroughly with 
PBS and incubated with a fluoresceinated anti-rabbit second layer antibody 
for  1 h under the same conditions. After further rinsing, the anti-myosin 
monoclonal antibody (1:100) was applied for 1 h. The myosin specific anti- 
body was rinsed away and a  rhodaminated, anti-mouse second layer ap- 
plied,  again for  1 h.  After further rinsing the cultures were mounted in 
anti-fade mountant (Citifluor, City of London Polytechnic, London, U.K.) 
and viewed at 300× magnification through the appropriate filters in a Zeiss 
IIIRS microscope equipped for epi-fluorescence. The cytoplasm surround- 
ing 200-300 nuclei from each culture, taken across the radius of the dish, 
were scored for the number showing positive staining, and the results then 
expressed as the percentage of nuclei in each dish surrounded by positively 
staining cytoplasm. Controls using the second layer antibodies alone showed 
no specific staining. Cultures were scored blind in order to avoid subjective 
bias. 
Immediately pre-fusion and  aligned myoblasts (50 h  of culture)  were 
stained for acetylcholine with a rabbit polyclonal antibody against glutar- 
aldehyde conjugated acetylcholine (Biosoft, France; Geffard et al.,  1985). 
The cultures were fixed for 1 rain in 2% formalin with 0.5 M allyl alcohol 
and 0.15 M cacodylate buffer, post-fixed in the absence of allyl alcohol for 
15 min, and then washed thoroughly with 0.1 M phosphate buffer. They were 
stained with the ACh antibody (1:100) in phosphate buffer with 0.1% Triton 
X-100 and 2% FCS (1:200)  for 1.5 h, washed, then exposed to biotinylated 
goat anti-rabbit antibodies (1:200)  for 1 h, washed thoroughly, and exposed 
to FITC-coupled Streptavidin for  1 h, washed thoroughly with phosphate 
buffer and mounted in anti-fade mountant. No specific staining was ob- 
served in controls using second layer antibodies only, when allyl alcohol 
was omitted from the fixative or if the cells were treated with Triton X-100 
before  fixation.  DNA content and total  Creatine phosphokinase activity 
were determined as described in Entwistle et al.  (1986). 
Guanidinium Uptake and Efflux 
10  -s M  ct-bungarotoxin was added to one set of dishes containing myo- 
blasts 30 h after plating 1 h before uptake measurement began. Immediately 
before the uptake measurements the culture medium was replaced by 700 
~tl isotonic-buffered sucrose (290 mM sucrose, 20 mM glucose, 5.4 mM 
KCI,  10 mM Hepes, set to pH 7.4 with Tris base). At time zero 48 t.tCi of 
[t4C]guanidinium  (specific  activity  48  mCi/mmol,  Amersham  Interna- 
tional,  U.K.) and sufficient carbachol  to  bring the final concentration to 
10  -s M were added to all dishes. 30 s later 4 dishes were taken from each 
set, rapidly, but gently, rinsed 7 times to remove the loading solution, and 
1 ml buffered sucrose containing Triton X-100 (0.1%) added to lyse the cells. 
Further sets of dishes were similarly treated at 1, 2, and 4 min after the addi- 
tion of labeled medium. The solution from each dish was taken up into 3 
ml of Ready-solv and counted in a liquid scintillation counter. The amounts 
of radioactivity contained by the cells at each time point were used to con- 
struct an uptake curve and the carbachol-induced uptake of guanidinium cal- 
culated as the difference between the uptake curves in the absence and pres- 
ence of a-bungarotoxin. 
Guanidinium efflux measurements  were made on immediately pre-fusion 
myoblasts and young myotubes. The cultures were exposed to [3H]guanidi- 
nium for 4-12 h to load them to equilibrium. They were rapidly rinsed five 
times to remove labeled guanidinium from the extracellular space and at 
time zero  1 ml of unlabeled medium of the same composition as the load 
solution added to each dish. The wash solution was withdrawn and replaced 
with  1 ml new solution at  15 s, 0.5- or  1-min intervals and after a  steady 
effiux rate  had been established solution containing  10-500 ~M  o-tubo- 
curare was added to the dish. Four samples were taken in the presence of 
dTc and the effiux solution then returned to normal medium. At the end of 
the efflux measurements the cells were lysed by the addition of 1 ml 0.1% 
Triton X-100 and the lysate counted to provide the radioactivity remaining 
within the cells. The rate constant (k) was calculated from the ratio of the 
effiux of radioactivity/min and the appropriate cumulative activity of the 
cells. 
Results 
Blocking the Nicotinic Acetylcholine Receptor Delays 
Myoblast Fusion 
When myoblast fusion has been delayed by preventing syn- 
thesis of  prostanoids, fusion can be induced by the acetylcho- 
line agonist,  carbachol.  The fusion-inducing effect of car- 
bachol  is  blocked by the  nicotinic acetylcholine receptor 
blocker,  ct-bungarotoxin, which does not affect fusion  in- 
duced by the addition of Prostaglandin E~  (PGE0  ~ (Entwis- 
tie et al., 1987). Fig.  1 a shows that a-bungarotoxin can also 
prevent spontaneous myoblast fusion, assessed at 54 h of cul- 
ture, when 40-50% fusion has taken place in controls, in a 
concentration-dependent manner. Inhibition was obvious at 
10 -9  M  and maximal at  10 -s M.  Cell number and myoblast 
alignment  were  unaffected.  In  keeping  with  the  results 
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a  Figure 1. Nicotinic acetylcho- 
line receptor blockers  inhibit 
myoblast  fusion.  Ordinates: 
Fusion Index, defined as % ex- 
perimental  fusion/%  control 
fusion.  Abscissae:  Concen- 
tration  of  receptor  blocker 
added to myoblast cultures. In 
,  ~  each  case  the  blocker  was 
io-lo  I0  -g  i0-a  added to the culture  medium 
8UNGaAOTOXIN  (M) 
at  44  h  of culture.  (a)  The 
effect of ct-bungarotoxin. (Sol- 
id square)  Fusion in uninhib- 
~  •  ~  ~  ited cultures. (Solid circles) Fu- 
sion in the presence of tt-bung- 
arotoxin.  (Open  circles)  Fu- 
sion induced by the addition of 
22 mM potassium in the pres- 
ence of a-bungarotoxin. (Open 
o  ....  square) Fusion induced by the  1  to  I0-9  10-8  10-7  la-6 
NAJA  TOXIN  (MI  addition  of Prostaglandin  E~ 
to toxin inhibited cultures. (b) 
Similar experiment with Naja 
}  ~  Naja toxin. Symbols as in (a). 
(c)  Experiment  using  mcAb 
5.5 to block AChRs. Concen- 
tration of antibody  in culture 
medium  given  as  mgm/ml. 
Symbols as in a. In each part 
of the figure the points give the 
~o  ~oo  mean  of four  culture  dishes 
mcAb 5.5  (/~g/ml)  and the bars  +1  SD. 
reported in the previous paper, either the addition of PGE~ 
(Fig.  1 a, open square) or raising potassium to 20 mM (Fig. 
1 a, open circles) overcame the block imposed by ct-bungaro- 
toxin, initiating fusion at the level observed in uninhibited, 
parallel cultures (Fig.  1 a, solid square).  In this particular 
experiment fusion  induced by potassium was substantially 
(fusion  index  1.4)  greater  than  spontaneous  fusion.  This 
was very unusual.  In all other experiments, potassium often 
caused  a  small  (10-15%)  stimulation  of fusion,  although 
there was no evidence for the induction of precocious fusion 
(see Entwistle et al.,  1988).  The reason for the substantial 
stimulatory  effect of potassium  in  this  experiment  is  not 
known.  Another  snake neuro-toxin,  Naja naja toxin,  that 
also binds to nicotinic acetylcholine receptors, was similarly 
effective in preventing spontaneous fusion of myoblasts (Fig. 
1 b). Both these snake toxins can bind tightly to sites other 
than acetylcholine receptors in some cell types (e.g., PC12 
cells,  Patrick and Stallcup,  1977).  Fig.  1 c,  (solid circles) 
shows that a monoclonal antibody (mcAb 5.5), which binds 
to and inactivates nicotinic acetylcholine receptors in chick 
muscle (Goldberg et al., 1983), was also able to inhibit spon- 
taneous myoblast fusion, the block again being overcome by 
the addition of 20 mM potassium (open circles).  As controls 
for an effect of nonspecific antibody binding we tested two 
other monoclonal antibodies, LB1 which also binds to chick 
myoblasts (Wakelam, M.  J.  D.,  personal communication), 
although  not  to  the  nicotinic  acetylcholine  receptor,  and 
A2E5.  At protein concentrations equivalent to those which 
1. Abbreviations  used in this paper:  PGEh Prostaglandin E~; CPK, crea- 
tine phosphokinase. 
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Figure 2. The gradual escape 
of myoblast fusion  from the 
inhibition  imposed by block- 
ing  acetylcholine  receptors 
with  ct-bungarotoxin.  Ordi- 
nate:  myoblast  fusion  (%). 
Abscissa:  time  after  plating 
(hours). (Open symbols) Myo- 
blast  fusion  in  control  cul- 
tures.  (Solid  symbols)  Myo- 
blast fusion in the presence of 
10  -5 M a-bungarotoxin. Toxin 
added at 44 h of culture. Each 
point gives the mean of four 
culture  dishes  and  the  bars 
indicate  1 SD.  Lines  drawn 
through points by eye. 
gave clear inhibitions with antibody mc Ab5.5 there was no 
inhibition of myoblast fusion by either antibody. 
The inhibition of spontaneous fusion achieved by blockers 
of nicotinic acetylcholine receptors was not complete and a 
low level of fusion, '~10-15 %, took place nevertheless (see 
Fig.  1 a). This low level of spontaneous fusion is similar to 
that  found  when  myoblast fusion  is delayed by  inhibiting 
prostanoid  synthesis  (Entwistle  et  al.,  1986).  Myoblasts 
eventually escaped from the inhibition of fusion imposed by 
blocking the nicotinic acetylcholine receptor.  Fig.  2  com- 
pares the time course of myoblast fusion in normal cultures 
(open circles) with the time course of fusion in the presence 
of 10  -8 M ct-bungarotoxin (solid circles).  At 54 h of culture 
fusion in toxin-containing cultures was still less than  15%, 
compared with 42 % in the parallel, untreated cultures. How- 
ever by 57  h,  fusion in toxin treated cultures had reached 
32 % and by 60 h it was no longer any different from the un- 
treated control. This suggests that during the inhibition there 
is a build-up of fusion-inducing agents other than those ac- 
tivating the nicotinic acetylcholine receptor that eventually 
overcomes the  toxin-induced  block.  A  similar escape oc- 
curred during treatment with Naja naja toxin and was noted 
previously during inhibition of prostanoid synthesis (Entwis- 
tie et al.,  1986). Repeated dosing with any of the acetylcho- 
line receptor blockers was unable to prolong the time course 
of the block, suggesting that the escape did not arise because 
of toxin coming off the cells.  Furthermore, treatment with 
both prostanoid synthesis inhibitors and blockers of the ace- 
tylcholine receptor was unable to prevent the eventual initia- 
tion  of spontaneous  myoblast fusion.  As  noted previously 
(Entwistle et al.,  1988), myoblast fusion must then proceed 
by yet another route. 
Table L Muscarinic Acetylcholine Antagonists Have No 
Effect on Myoblast Fusion 
Antagonist  Concentration  Fusion index 
Atropine  10  -~ M  0.99  +  0.04 
N-Methyl scopolamine  10  -9 M  0.97  +  0.07 
10  -s M  0.83  +  0.07 
QNB  10  -s M  1.09  4-  0.06 
10  -~ M  1.03  +  0.05 
All values give the mean  + 1 SD of four dishes. In each case the drug was 
added after 24 h in culture and the assay carried out at 52 h of culture. A second 
dose of QNB  10  -6 was added  at 42 h. 
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Figure 3.  Curare can act as a 
fusion-inducing agent in chlo- 
roquine-inhibited  cultures. 
Ordinate:  fusion  index.  Ab- 
scissa:  agonist  concentration 
(M). Open square: control fu- 
sion  in  parallel,  uninhibited 
cultures.  (Solid square) Fu- 
sion  in chloroquine-inhibited 
cultures.  (Open circles) Fu- 
,  ,  ,  ~ ,  .....  sion  in  the  presence  of car- 
10  -~  :o-'  bachol. (Solid circles) Fusion 
AGON~Sr ~M~  in the presence of o-tubocu- 
rare.  Carbachol or D-tubocurare added at 54 h of culture.  Each 
point gives the mean +1 SD of four culture dishes except for con- 
trol where 8 dishes were used. Line drawn through points by eye. 
Table I shows that antagonists to muscarinic acetylcholine 
receptors  (atropine,  quinuclidinylbenzilate  [QNB],  and 
N-methyl scopolamine) had little or no effect on myoblast fu- 
sion  when  applied  at  concentrations  which  would  be  ex- 
pected to block specifically muscarinic receptors.  However, 
atropine concentrations  above  1 IxM,  where block of nico- 
tinic acetylcholine receptors is known to occur (Feltz et al., 
1977),  did suppress myoblast fusion.  In 5  experiments  (20 
dishes) control  fusion was 45.2  _  2.8%  (+1  SEM).  In the 
presence of 1 ~  Atropine,  fusion fell to 14.5  +  4.3%  (+1 
SEM, n  =  5, 20 dishes). Taken together these results confirm 
that nicotinic,  rather than muscarinic,  acetylcholine  recep- 
tors are involved. 
If activation  of nicotinic  acetylcholine  receptors  is  in- 
volved in myoblast fusion, then o-tubocurare,  a well known 
antagonist  of acetylcholine  at the neuromuscular junction, 
might be expected to prevent the spontaneous fusion of myo- 
blasts.  However no inhibition of fusion was found with  10  -3 
or  10  -6 M  o-tubocurare.  Fig.  3  shows that,  in chloroquine- 
inhibited cultures,  o-tubocurare (solid circles) proved to be 
an effective fusion-inducing  agent,  equivalent  to carbachol 
(open circles). The agonist action of n-tubocurare could be 
prevented  by  a-bungarotoxin  (10  -8  M).  This  apparently 
anomalous finding might be explained if the drug acts as an 
agonist to the acetylcholine receptor on chick myoblasts, as 
described in rat myoblasts and young myotubes (Trautman, 
1982; Takeda and Trautman,  1984).  Experiments to test this 
possibility directly were made by following the efflux of gua- 
nidinium  ions,  which can permeate the ACh receptor acti- 
vated channel,  in the absence and presence of 10-500  lxM 
n-tubocurare.  On some occasions a significant efflux of gua- 
nidinium  ions was induced  by dTC and reduced  by ct-bun- 
garotoxin,  consistent with an agonist action at the ACh re- 
ceptor.  The  variability  of the  response  could  arise  if the 
agonist action was short-lived and followed by antagonistic 
effects. However these experiments do not exclude the possi- 
bility that dTC induces myoblast fusion by some completely 
separate mechanism. 
Nicotinic Acetylcholine Receptor Blockers do not 
Inhibit Myoblast Differentiation 
Although nicotinic antagonists delayed myoblast fusion, the 
block could be completely overcome by raising extracellular 
potassium  or the addition  of PGE,.  This  suggests that the 
inhibition  operates  at the  level  of myoblast  fusion,  rather 
than  reflecting  a  general  effect on myoblast differentiation. 
This is supported by measurements of several other proper- 
ties of myoblasts that are known to change in the course of 
normal myogenesis in vitro.  Table II shows that at 54 h  of 
culture cholinergic antagonists had no effect on the changes 
in the cell number, DNA content, level of total creatine phos- 
phokinase (CPK) activity, appearance of the muscle specific 
CPK  isozyme and  the appearance of myosin heavy chains 
Table 11. Nicotinic Acetylcholine Receptor Antagonists Block Myoblast Fusion but Have No Effect on Cytodifferentiation 
Control 
Bungarotoxin  Naja toxin  Atropine 
24h  54h  54h  54 h  54h 
10  ~ M  ]0  -7 M  10  '~ M 
Percent fusion  none detected  42.8  _+  2.5  113.7  +_  2.7  14.8  +  1.5  14.6  _+  1.5 
Cell No.  × 
10-3/sq cm  16.7  +  1.5  40.8  _+  6.1  43.6  _+  6.1  38.5  _+  4.0  45.1  +  6.1 
DNA  Ixg/sq cm  67  +  15  104  _+  4.0  119  +_  9.0  123  _+  17  116  +  6 
Total CPK  nmol/ 
min/~tg DNA  10.3  +  3.1  44.8  +  10.8  38.6  +  5.3  44.6  +  6.4  40.8  +  5.5 
+ve M-CPK  (%)  12.6  +_  8.0  61.4  _+  5.6  65.7  +  1.1  ND  ND 
+ve myosin (%)  13.5  _+  4.5  64.5  +  0.3  64.6  ___  1.7  ND  ND 
ND  =  not determined.  Values given/sq cm refer to sq cm of culture dish. All values given mean  + 1 SD of four parallel dishes.  They represent  examples drawn 
from  at least 3 measurements  of each  parameter, carried out in various combinations. 
The apparent  discrepancy between  the increase in cell number and the increase in DNA content  between  24 and 54 h of culture arises because  at 24 h many 
cells have replicated their DNA,  but have  not yet undergone  cytokinesis. 
Figure 4. Pre-fusion myoblasts contain ct-bungarotoxin-binding sites indicating the presence of acetylcholine receptors. (a and b) Phase- 
contrast (a) and bright-field (b) images of single bipolar myoblast after 30 h in culture.  Note silver grains over the myoblast indicating 
specific binding of labeled ct-bungarotoxin.  (c and d) Another single myoblast at 30 h in culture. (e and f) Phase-contrast (e) and bright-field 
(f) images of field showing both myoblasts and fibroblasts. Note only myoblasts show silver grains reflecting  ~t-bungarotoxin  binding. (g 
and h) Field of aligning myoblasts at 48 h in culture to show specific toxin binding. Note some myoblasts (arrows) have very low binding 
levels.  (i and j) Field of myotubes at  144 h in culture showing dense labeling with a-bungarotoxin and at least one hot spot. 
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Figure 5.  Carbachol induces 
uptake of [t4C]guanidinium  in 
fusing  myoblasts.  Ordinate: 
dpm x  10  -3 per dish. Abscis- 
sa: time after beginning of up- 
take (minutes). (Open circles) 
Uptake of guanidinium in the 
presence of 10 gM carbaehol. 
(Open squares) Uptake  of gua- 
nidinium in  presence of  10 
gM  carbachol and  10  -8  M 
tz-bungarotoxin to block up- 
take  through acetylcholine 
receptors.  (Solid circles)  Carbachol induced uptake of  gua- 
nidinium, calculated as the difference in uptake in the presence and 
absence of ~t-bungarotoxin. 
that accompany normal myoblast differentiation. When as- 
sessing the proportion of nuclei surrounded by cytoplasm 
positively stained for the CPK isozyme or myosin heavy 
chains, no specific precautions were taken to differentiate be- 
tween fused and unfused myoblasts since cultures containing 
predominantly unfused cells  nevertheless  showed a  high 
proportion of positive staining. 
Myoblasts Possess a-Bungarotoxin-binding Sites and 
Functional Acetylcholine Receptors 
The appearance and distribution of ¢t-bungarotoxin-binding 
sites, was determined by autoradiography of myoblast cul- 
tures exposed to ~5I-labeled  a-bungarotoxin. Fig. 4  shows 
sample autoradiographs made from myoblast cultures before 
fusion begins (30 h), at the beginning of the main burst of 
spontaneous fusion (48 h), and after the formation of myo- 
tubes (144 h). Bipolar, single cells in both 30- and 48-h cul- 
tures bound ct-bungarotoxin (Fig. 4, a-f),  although fibro- 
blasts did not. At 30 h 23.7 -l- 2.8% (mean +SEM; 3 dishes) 
of solitary bipolar cells showed clear ct-bungarotoxin-bind- 
ing, while a higher percentage (53.3 +  4.0%; mean +SEM; 
3 dishes) of aligned myoblasts were labeled. At 48 h aligning 
myoblasts (Fig. 4, g and h) again showed specific binding of 
labeled toxin, although not all cells were labeled. After 144 h 
in culture, when extensive chains of myotubes had formed, 
both diffuse toxin binding and hot spots were evident (Fig. 
4, i and j). Comparison of the level of binding sites in myo- 
tubes (Fig. 4j) with that in single myoblasts (Fig. 4, b and 
d) shows that some myoblasts possess a high density of toxin- 
binding sites, similar to that in formed myotubes. The bind- 
ing of a-bungarotoxin could be prevented if either carbachol 
(10  -3 M) or D-tubocurare (10  -3 M) was included in the medi- 
um during labeling. 
For acetylcholine to be a plausible fusion-inducing stimu- 
lus during myogenesis in culture, it is necessary to show that 
the myoblast membrane contains functional nicotinic acetyl- 
choline receptors.  We therefore tested whether carbachol 
was able to produce an increase in the sodium permeability 
of pre-fusion myoblasts. The uptake of [t4C]guanidinium, 
which has been shown to permeate through acetylcholine 
receptors channels in skeletal muscle (Dwyer et al.,  1980), 
was used to indicate the uptake of sodium. The experiments 
were made on myoblast cultures at 30 h in culture. Fig. 5 
shows the uptake by myoblasts of [t4C]guanidinium  evoked 
by 10  -5 M carbachol in the absence (open circles) and pres- 
ence (open  squares)  of 10  -8 M  ct-bungarotoxin. The cells 
were preincubated with the toxin for  1 h before measure- 
ments began. The solid circles give the carbachol induced 
uptake through the a-bungarotoxin sensitive pathway. These 
observations suggest that the pre-fusion myoblast membrane 
contains functional acetylcholine receptors. 
Myoblasts Express Choline Acetyltransferase Activity 
and Bind ACh Antibodies 
The finding that blocking nicotinic acetylcholine receptors 
can delay the spontaneous fusion of  cultured myoblasts raises 
the possibility that some cells in the cultures, possibly myo- 
blasts themselves, synthesize and release acetylcholine or a 
similar agonist. To test whether myoblasts might be able to 
synthesize acetylcholine, cultures of myoblasts and myo- 
tubes were assayed for the presence of the synthetic enzyme 
choline acetyltransferase (CHAT) using a modification of an 
existing procedure (see Materials and Methods). 
Control experiments showed that the endogenous level of 
carnitine acetyltransferase activity, which might complicate 
estimates of ChAT activity (Rossier,  1977; Goodman et al., 
1984),  in myoblasts after 50 h  of culture was  378  5:75 
IxU/culture dish (416 +  8 lxU/mgm protein, n =  6). The syn- 
thesis of acetylcarnitine was not sensitive to acetylcholine- 
Table III.  The Levels of Choline Acetyl Transferase Activity in Myogenic Cultures 
Activity 
ChAT activity  pmol/ 
Time in culture  Blank  +Physo  +ACHE  min per mgm protein 
dpm (n) 
Experiment  1 
50 h*  281  +  32  (6)  607  +  75  (5)  292  _+  61  (6)  3.3  +  0.84 
96 h*  277  +  17 (6)  1187  +  73  (6)  678  _  96 (6)  2.68  +  0.7 
144 h*  299  +  64 (6)  1242  -I-  106 (6)  494  ___  85  (6)  5.58  -I-  1.4 
Experiment 2 
50 h*  326  -I-  22  (6)  536  +  48  (5)  287  _+  43  (5)  3.2  +  0.7 
BUDR treated 50 h  447  ±  59 (6)  781  ±  77  (6)  651  _  72  (6)  1,04  ±  1.1 
Fibroblasts  280  ±  19 (6)  480  +  84  (6)  383  ±  33  (6)  0.9  ±  0.9 
Each figure gives the mean + 1 SD with the number of replicates in parentheses. 
* Activity in the presence of physostigmine significantly greater than in the presence of AChE (P < 0.05; Mann-Whitney Test. Cells were plated at a density of 
8  x  104/sq cm BUDR (1  ×  10  -5 M) added at 6 h of culture and again at the medium change (24 h). 
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and Amano, 1974). When 1 mU of pigeon breast muscle car- 
nitine acetyltransferae (twice the endogenous level at 50 h) 
was incubated with 2.7 mM choline as in the standard assay 
(see  Materials and Methods),  the activity in the organic 
phase was no different from background.  10 mU earnitine 
acetyltransferase gave detectable levels of radioactivity (*5 
times background). 
The outcome of  ChAT assays is shown in Table III. In 50-h 
cultures of myoblasts, when fusion is just beginning, the or- 
ganic phase clearly contained detectable radioactivity, which 
was abolished completely by the inclusion of AChE in the in- 
cubation medium. This suggests that at 50 h the cells possess 
ChAT  activity,  Cultures  treated  with bromodeoxyuridine 
(BUDR) showed a low level of activity, which was not sensi- 
tive to incubation with ACHE, suggesting that ChAT levels 
were much reduced. At 96 h, by which time fusion should 
be  maximal, the myoblasts showed an increased level  of 
AChE sensitive activity, suggesting that ChAT activity was 
maintained although acetylation of choline by increased lev- 
els of carnitine acetyltransferase cannot be ruled out (see 
Goodman et al., 1984). The esterase insensitive activity in- 
creased also, which would be consistent with a concomitant 
rise in carnitine acetyltransferase activity or endogenous lev- 
els of carnitine. Older cultures containing myotubes (144 h) 
retained significant levels of AChE sensitive activity, while 
there was little increase in the activity expressed in the pres- 
ence of ACHE. Table HI shows also that ChAT activity in cul- 
tures of fibroblast-like cells, derived from myogenic cultures 
by repeated sub-passaging, was substantially lower than in 
the myoblast cultures, making it unlikely that the ChAT activity 
in the myoblast cultures came from contaminating fibroblasts. 
These measurements indicate that myoblasts at the time of 
fusion and, possibly, myotubes possess choline acetyltrans- 
ferase activity. 
Although it is likely that the radioactive compound ex- 
tracted into the organic phase in these experiments was ace- 
tylcholine, this remains to be proved. As an alternative, we 
tested whether cultures at 50 h, which contain bipolar myo- 
blasts, aligning myoblasts, and the earliest myotubes, specifi- 
cally bound antibodies to acetylcholine. Fig. 6 shows photo- 
graphs of bipolar myoblasts and aligned myoblasts which 
show specific binding of an antibody to ACh (a-d), com- 
pared with binding in controls in which allyl alcohol was 
omitted from the fixative (g) or Triton X-100 was applied be- 
fore fixation (e and f). Epithelial cells showed no specific 
binding of ACh antibodies (arrows in a  and b). Thus it is 
likely that bipolar myoblasts and aligning myoblasts not only 
possess ChAT activity, but also synthesize acetylcholine. 
Discussion 
This paper provides evidence that myoblasts in culture are 
provoked to fuse and form myotubes by activation of the 
nicotinic acetylcholine receptor; an agonist at the ACh re- 
ceptor could be an endogenous fusion-inducing substance. 
Thus spontaneous fusion can be delayed by blocking nico- 
tinic acetylcholine receptors, pre-fusion myoblasts possess 
ct-bungarotoxin-binding sites and activation of  myoblast ace- 
tylcholine receptors produces an increase in membrane per- 
meability to guanidinium ions, which are known to permeate 
the ACh channel in the same way as sodium. Furthermore 
pre-fusion myoblasts specifically bind antibodies to ACh and 
express the enzyme CHAT, which is associated with the syn- 
thesis of acetylcholine (Moolenar and Polak,  1980; Miledi 
et al., 1982). The ionic basis of myoblast fusion induced by 
activation of the acetylcholine receptor was discussed in the 
previous paper  (Entwistle et al.,  1988)  and is  not recon- 
sidered here. 
The identification of the nicotinic, rather than the mus- 
carinic, acetylcholine receptor as the mediator of myoblast 
fusion rests on comparison of the ability of known nicotinic 
and muscarinic acetylcholine receptor antagonists to inhibit 
spontaneous myoblast fusion. Of the muscarinic antagonists, 
atropine was able to delay myoblast fusion, but only at con- 
centrations well above those at which it blocks muscarinic 
receptors in other tissues, when it is known also to bind to 
nicotinic receptors (Feltz et al., 1977). Further support comes 
from the specific binding of labeled a-bungarotoxin to pre- 
fusion myoblasts and the finding that toxin binding could be 
prevented by carbachol and o-tubocurare. 
The inhibition of myogenesis imposed when the nicotinic 
acetylcholine receptor is blocked is restricted to the preven- 
tion of myoblast fusion. Cell division and the alignment of 
myoblasts in preparation for fusion are unaffected, as is the 
increase in creatine phosphokinase activity and the appear- 
ance of myosin, which are both considered to reflect early 
steps in muscle differentiation. The block is therefore very 
similar to that achieved by inhibiting prostanoid synthesis 
(Entwistle et al., 1986). These observations support a grow- 
ing body of evidence that the link between myotube forma- 
tion and the differentiation of the phenotypic properties of 
muscle can be dissociated. Thus blocking the acetylcholine 
receptor, inhibiting prostanoid synthesis and lowering exter- 
nal calcium to ~1/10 of its normal level (see Entwistle et al., 
1988) all seem to affect the fusion process alone. Manipula- 
tion of the ionic environment also can either prevent or pro- 
mote fusion depending on the particular conditions chosen 
(see Entwistle et al., 1988). The ability to separate these two 
processes in a variety of ways should aid analysis of the un- 
derlying control mechanisms. 
Carbachol induced an ct-bungarotoxin  sensitive, uptake of 
guanidinium ions in fusing myoblasts. This is the counterpart 
to the demonstration that sodium ions must be present in the 
medium for the  acetylcholine agonist to act as  a  fusion- 
inducing agent (Entwistle et al.,  1988)  and reinforces the 
suggestion that depolarization of the myoblast membrane is 
an integral part of the initiation of myoblast fusion (Entwistle 
et al.,  1988). 
Both myoblasts and myotubes express enzyme activity that 
is probably, although not certainly, choline acetyltransferase. 
The partition of ACh into tetraphenylboron at pH 7.0 has 
been shown to be specific (Fonnum, 1975; Tucek et al., 1978) 
and myoblasts were labeled specifically with an antibody to 
acetylcholine. It is unlikely that contaminating fibroblasts 
are the source of acetylcholine in the cultures because they 
contain much less ChAT than myoblasts and did not bind the 
ACh antibody. In addition, fibroblasts form a relatively small 
proportion of the cells in the cultures, since 80% of cells are 
destined to form myotubes, setting the maximal likely con- 
tamination with non-myogenic cells at 20%. 
The Control of  Spontaneous Myoblast Fusion 
Evidence has been accumulating that prostanoids may be in- 
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Entwistle et al.  1986; David and Higginbotham,  1981). Part 
of this evidence rests on the finding that spontaneous fusion 
of myoblasts in culture is substantially delayed when prosta- 
noid synthesis is inhibited. The observation that blocking the 
acetylcholine receptor also substantially delays spontaneous 
fusion poses a number of questions about the control of myo- 
blast fusion both in vitro and in vivo. The two pathways can 
be activated independently. However the effective concentra- 
tion for PGErinduced fusion is increased when the acetyl- 
choline  receptor  is  blocked  (Entwistle  et  al.,  1988)  and 
preventing activation through either pathway is sufficient to 
delay spontaneous fusion in vitro (this paper and Entwistle 
et al.,  1988). This suggests that cultured myoblasts produce 
subthreshold amounts of more than one fusion-inducing agent 
and the two pathways act synergistically during spontaneous 
fusion. One of these agents is probably a prostanoid (Zalin, 
1977; Entwistle et al.  1986; David and Higginbotham, 1981). 
The other acts at the nicotinic ACh receptor and might be 
acetylcholine itself, although the present results do not allow 
its unequivocal identification. The situation during normal 
development is more difficult to define. Prostaglandins and 
prostanoid-binding sites have been detected in differentiating 
myoblasts (Hausman et al.,  1986; Zalin,  1987). 
Both innervated and denervated frog and rat muscle have 
been shown to synthesize acetylcholine (Miledi et al.,  1977, 
1978, 1981), although its functional role has not been iden- 
tified.  The presence of ChAT activity in young myotubes 
would not, therefore, be totally unexpected. However, the 
demonstration of ChAT activity does not, in itself, mean that 
either myoblasts or myotubes are synthesizing acetylcholine. 
The activity could be masked functionally and only released 
from the inactive form during the lysis necessary to carry out 
the assay. The finding that myoblasts bind specifically an ace- 
tylcholine antibody is more convincing. Muscle synthesized 
acetylcholine may persist for some time and could assist the 
accretion of myoblasts during myotube formation. 
The earliest motoneurons enter the muscle mass very early 
in development (Landmesser, 1978) and may secrete acetyl- 
choline during neurite elongation (Young  and Pod,  1984). 
Thus the present findings raise the interesting possibility that 
neurons have a role in myoblast fusion. It will be interesting 
to know whether young myotubes retain the ability to synthe- 
size ACh after the arrival of the motoneuron, and whether 
the fusion-inducing effect of any ACh released from muscle 
is additive with that released by innervating motoneurons. 
However any involvement of neuronaUy released acetylcho- 
line cannot be obligatory since differentiated muscles, albeit 
rather small in size, can be found in limbs deprived of motor 
innervation before the motor nerves have entered the limb. 
It is perhaps more plausible to suppose that neuronal activa- 
tion of acetylcholine receptors may assist the continual ac- 
cretion of myoblasts into myotubes and in the formation of 
secondary myotubes. Muscles formed in the absence of in- 
nervating motoneurons may be small not only because of the 
absence of electrically driven motor activity, but also be- 
cause fewer myotubes are formed in these circumstances. 
One consistent feature of the results is the gradual escape 
of the myoblasts from inhibitions of fusion imposed either 
by reducing prostanoid synthesis or by including blockers of 
nicotinic  acetylcholine receptors  in  the  culture  medium. 
This suggests that myoblasts are able to fall back on yet an- 
other  fusion-inducing  mechanism  which  comes  into  play 
when fusion is greatly delayed. The present results shed no 
light on this auxiliary mechanism, but it could be related to 
the presence of membrane receptors to ATP (Kolk and Wake- 
lam,  1983; Hume and Honig,  1986) and we now have evi- 
dence to suggest that this is the case (Entwistle and Bevan, 
manuscript in preparation). The presence of three, appar- 
ently independent mechanisms each of which leads to myo- 
blast fusion,  implies that this event is of such importance 
during myogenesis that natural selection has ensured a very 
large safety factor. 
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